Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing oral liquid vs Shuanghuanglian oral liquid in acute upper respiratory infection (wind-heat pattern)
CTR20140022Phase 3Completed
- Sponsor
- Henan Xinyi Pharmaceutical
- Start
- May 2014
- Countries
- 1
01
Overview
A Phase 3 trial of tanreqing in upper respiratory infection (URI), nasopharyngitis, Bacterial pharyngitis, bacterial pharyngotonsillitis, sponsored by Henan Xinyi Pharmaceutical. Started May 2014; status: completed.
02
Drugs
tanreqing
03
Conditions
upper respiratory infection (URI)nasopharyngitisBacterial pharyngitisbacterial pharyngotonsillitis
Beyond the preview
Go deeper on CTR20140022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140022.